1. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35(10):S65-S164. [
DOI:10.1016/j.ajic.2007.10.007] [
PMID] [
]
2. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(10):S165-S93. [
DOI:10.1016/j.ajic.2007.10.006] [
PMID]
3. MacVane SH. Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections. J Intensive Care Med 2017;32(1):25-37. [
DOI:10.1177/0885066615619895] [
PMID]
4. Frattari A, Savini V, Polilli E, Di Marco G, Lucisano G, Corridoni S, et al. Control of Gram-negative multi-drug resistant microorganisms in an Italian ICU: Rapid decline as a result of a multifaceted intervention, including conservative use of antibiotics. Int J Infect Dis 2019;84:153-62. [
DOI:10.1016/j.ijid.2019.04.002] [
PMID]
5. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, Han C, Bisignano C, Rao P, Wool E, Johnson SC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399(10325):629-55. [
DOI:10.1016/S0140-6736(21)02724-0] [
PMID]
6. Rasool MH, Zaheer M, Hassan MF, Shafique M, Qamar MU. Isolation and Antimicrobial Susceptibility Paradigm of Carbapenem Resistant Metallo-Beta-Lactamase Producing Gram Negative Rods. Pak J Zool 2019;51(3):849. [
DOI:10.17582/journal.pjz/2019.51.3.849.854]
7. Capsoni N, Bellone P, Aliberti S, Sotgiu G, Pavanello D, Visintin B, et al. Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria. Multidiscip Respir Med 2019;14:1-11. [
DOI:10.1186/s40248-019-0185-4] [
PMID] [
]
8. Hemmati A, Nikoonejad A, Lotfollahi L, Jahed S, Nejadrahim R, Nabizadeh E, et al. Antibiotical Resistance Pattern of Microorganisms Isolated From Positive Blood Cultures At Icus of Imam Khomeini Hospital. Stud Med Sci 2016;27(6):533-40. [
Google Scholar]
9. Yousefipour M, Rasoulinejad M, Hadadi A, Esmailpour N, Abdollahi A, Jafari S, et al. Bacteria producing extended spectrum β-lactamases (ESBLs) in hospitalized patients: Prevalence, antimicrobial resistance pattern and its main determinants. Iran J Pathol 2019;14(1):61. [
DOI:10.30699/ijp.14.1.61] [
PMID] [
]
10. Organization WH. Antimicrobial resistance: global report on surveillance: World Health Organization; 2014. [
Google Scholar]
11. David MZ, Dryden M, Gottlieb T, Tattevin P, Gould IM. Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new. Int J Antimicrob Agents 2017;50(3):303-7. [
DOI:10.1016/j.ijantimicag.2017.05.006] [
PMID]
12. Sanchez GV, Babiker A, Master RN, Luu T, Mathur A, Bordon J. Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012. Antimicrob Agents Chemother 2016;60(5):2680-3. [
DOI:10.1128/AAC.02897-15] [
PMID] [
]
13. Mandal J, Acharya NS, Buddhapriya D, Parija SC. Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli. Indian J Med Res 2012;136(5):842-9. [
PMID]
14. Afkhamzadeh A, Lahoorpour F, Delpisheh A, Janmardi R. Incidence of ventilator- associated pneumonia (VAP) and bacterial resistance pattern in adult patients hospitalised at the intensive care unit of Besat Hospital in Sanandaj. Sci J Kurdistan Univ Med Sci 2011;16(1):20-6. [
Google Scholar]
15. Mahmoudi H, Alikhani M Y, Arabestani M, Khosravi S. Evaluation Prevalence agents of urinary tract infection and antibiotic resistance in patients admitted to hospitals in Hamadan University of Medical Sciences 1391-92. Pajouhan Sci J 2014;12(3):20-7. [
Google Scholar]
16. Zervos MJ, Hershberger E, Nicolau DP, Ritchie DJ, Blackner LK, Coyle EA, et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 2003;37(12):1643-8. [
DOI:10.1086/379709] [
PMID]
17. Ena J, Amador C, Martinez C, Ortiz de la Tabla V. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol 1995;153(1):117-20. [
DOI:10.1097/00005392-199501000-00040] [
PMID]
18. Moremi N, Mushi MF, Fidelis M, Chalya P, Mirambo M, Mshana SE. Predominance of multi-resistant gram-negative bacteria colonizing chronic lower limb ulcers (CLLUs) at Bugando Medical Center. BMC Res Notes 2014;7:211. [
DOI:10.1186/1756-0500-7-211] [
PMID] [
]
19. Shams F, Hasani A, Pormohammad A, Rezaee MA, Reza M, Nahaie AH, et al. qnrA implicated quinolone resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates from a University Teaching Hospital. Life Sci J 2014;11(12s):1032-5. [
Google Scholar]
20. Rezaee MA, Sheikhalizadeh V, Hasani A. Detection of integrons among multi-drug resistant (MDR) Escherichia coli strains isolated from clinical specimens in northern west of Iran. Braz J Microbiol 2011;42(4):1308-13. [
DOI:10.1590/S1517-83822011000400010] [
PMID] [
]
21. Salem MM, Magdy M, Alhosiny IM. Distribution of classes 1 and 2 integrons among multi drug resistant E. coli isolated from hospitalized patients with urinary tract infection in Cairo, Egypt. Aust J Basic Appl Sci 2010;4(3):398-407. [
Google Scholar]
22. Kibret M, Abera B. Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia. Afr Health Sci 2011;11 Suppl 1(Suppl 1):S40-5. [
DOI:10.4314/ahs.v11i3.70069] [
PMID] [
]
23. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 2001;45(5):1402-6. [
DOI:10.1128/AAC.45.5.1402-1406.2001] [
PMID] [
]